MAB was given emergency use authorization by the FDA last October for non hospitalized co vid patients, although the need for such antibody drugs has dwindled as vaccines become more widely available.
MAB在去年10月獲得FDA的緊急使用授權,用於非住院的co vid患者,儘管隨著疫苗變得更加廣泛,對這種抗體藥物的需求已經減少。